- 期刊
Non-alcoholic Steatohepatitis: An Overview
若您是本文的作者，可授權文章由華藝線上圖書館中協助推廣。
並列摘要
Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of fat-induced liver injury, ranging from mild steatosis to cirrhosis and liver failure. The presence of obesity and insulin resistance is strongly associated with non-alcoholic fatty liver and a greater risk of advanced disease. We present here a review of the mechanisms involved in the pathogenesis of NAFLD, advances in the diagnosis, and options for treatment.
延伸閱讀
- Busafi, S. A. A., Bhat, M., Wong, P., Ghali, P., & Deschenes, M. (2012). Antioxidant Therapy in Nonalcoholic Steatohepatitis. Hepatitis Research and Treatment, 2012(), 87-94. https://doi.org/10.1155/2012/947575
- 周鈴泰、夏幸賢、張偉煌（2005）。Nonalcoholic Steatohepatitis。內科學誌，16(6)，253-259。https://doi.org/10.6314/JIMT.2005.16(6).01
- 謝孟軒（2006）。The influence of hepatic steatosis to chronic hepatitis C〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://doi.org/10.6832/KMU.2006.00004
- 廖敏策、謝博軒（2007）。Adiponectin and Nonalcoholic Fatty Liver Disease。內科學誌，18(2)，70-77。https://doi.org/10.6314/JIMT.2007.18(2).02
- 許景盛（2022）。Extra-Hepatic Manifestations of Non-Alcoholic Fatty Liver Disease。台灣醫學，26(3)，328-335。https://doi.org/10.6320/FJM.202205_26(3).0007